Comprehensive Cancer Centre The Netherlands
23
8
11
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 70/100
13.0%
3 terminated/withdrawn out of 23 trials
50.0%
-36.5% vs industry average
13%
3 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
High-Risk prostatE Cancer radiatiOn Versus surgERy
Role: lead
Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation
Role: collaborator
Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases
Role: collaborator
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Role: collaborator
Postoperative Re-irradiaTion With and Without HYPERthermia: Toxicity, Quality of Life and Survival in Patients With Locoregional Recurrent Breast Cancer
Role: collaborator
Effectiveness of Online ACT for Pain Interference in Cancer Survivors With Chronic Painful CIPN
Role: collaborator
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Role: collaborator
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Role: collaborator
Symptom Management Essentials at Home
Role: collaborator
Mitigating Toxicity by Electronic Health Portal-mediated Interactive Monitoring of Patient-reported Side Effects
Role: collaborator
Prediction Models for Complications After CRT in Esophageal Cancer
Role: collaborator
ENdometrial Cancer SURvivors' Follow-up carE (ENSURE): Less is More?
Role: lead
Distress In CErvical Cancer Patients and Partners
Role: lead
Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer
Role: collaborator
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
Role: collaborator
Impact of Nationwide Enhanced Implementation of Best Practices in Pancreatic Cancer Care (PACAP-1)
Role: collaborator
Effectiveness of Personalized Surveillance and Aftercare for Breast Cancer
Role: lead
Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy
Role: collaborator
Pancreatic Locally Advanced Irresectable Cancer Ablation
Role: collaborator
ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers
Role: collaborator